Survival in Asian Americans After Treatments for Hepatocellular Carcinoma: A Seven-year Experience at UCLA

Journal of Clinical Gastroenterology

Volumn 44, Issue 3, 2010, Pages e63-e70

  Tong, Myron J ^a   Chavalitdhamrong, Disaya ^a   Lu, David S K ^b   Raman, Steven S ^b   Gomes, Antoinette ^b   Duffy, John P ^b   Hong, Johnny C ^b   Busuttil, Ronald W ^b  

^a The Dumont UCLA Liver Cancer Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Asian Americans; Hepatitis B; Hepatitis C; Hepatocellular carcinoma; Liver transplantation

Indexed keywords

ADULT; ARTICLE; ASIAN AMERICAN; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SURVIVAL RATE; TUMOR CLASSIFICATION;

AGED; ALGORITHMS; ASIAN AMERICANS; CALIFORNIA; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS C; HUMANS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 77649281400     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181b4b68b     Document Type: Article

References (30)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001;2:533-543.
2. El-Serag HB, Rudolph L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557-2576.
3. Szmuness W, Stevens CE, Ikram H, et al. Prevalence of hepatitis B virus infection and hepatocellular carcinoma in Chinese-Americans. J Infect Dis. 1978;137:822-829.
4. El-Serag HB, Davila JA, Petersen NJ, et al. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med. 2003;139:817-823.
5. Barazani Y, Hiatt JR, Tong MJ, et al. Chronic viral hepatitis and hepatocellular carcinoma. World J Surg. 2007;31:1243-1248.
6. Ikeda K, Marusawa H, Osaki Y, et al. Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study. Ann Intern Med. 2007;146:649-656.
7. Nguyen MH, Keeffe EB. Chronic hepatitis B and hepatitis C in Asian Americans. Rev Gastroenterol Disord. 2003;3:125-134.
8. Cheng JT, Hsien C, Sun HE, et al. The emerging importance of chronic hepatitis C infection in Asian Americans. Am J Gastroenterol. 2006;101:2737-2743.
9. McCracken M, Olsen M, Chen MS Jr, et al. Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin. 2007;57:190-205.
10. Reeves TJ, Bennett CE. We the people: Asians in the United States. Census 2000 Special Reports, CENSR-17. Washington, DC: US Census Bureau; 2004:1-20.
11. Tong MJ, Yu M, Co R, et al. Hepatitis B markers on foreign-born Chinese population of Los Angeles, California. J Infect Dis. 1984;149:475.
12. Tong MJ, Huang SJ. Hepatitis B virus infection in Asian Americans. Gastroenterol Clin N Am. 1994;23:523-536.
13. Hann HW, Hann RS, Maddrey WC. Hepatitis B virus infection in 6,130 unvaccinated Korean-Americans surveyed between 1988 and 1990. Am J Gastroenterol. 2007;102:767-772.
14. Umemura T, Kiyosawa K. Epidemiology of hepatocellular carcinoma in Japan. Hepatol Res. 2007;37(suppl 2):S95-S100.
15. Shin HR. Epidemiology of hepatitis C virus in Korea. Intervirology. 2006;49:18-22.
16. Lee CM, Hung CH, Lu SN, et al. Viral etiology of hepatocellular carcinoma and HCV genotypes in Taiwan. Intervirology. 2006;49:76-81.
17. Tong MJ, Blatt LM, Tyson KB, et al. Death from liver disease and development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection: a prospective study. Gastroenterol Hepatol. 2006;2:41-47.
18. Tong MJ, Blatt LM, Kao JH, et al. Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: a comparison with chronic carriers. Liver Int. 2007;73:1478-1485.
19. Ryu T, Nishimura S, Miura H, et al. Thrombopoietin-producing hepatocellular carcinoma. Intern Med. 2003;48:730-734.
20. Georgiades CS, Hong K, Geschwind JF. Radiofrequency ablation and chemoembolization for hepatocellular carcinoma. Cancer J. 2008;14:117-122.
21. Lu DS, Yu NC, Raman S, et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatoglogy. 2005;41:1130-1137.
22. El-Serag HB, Marrero JA, Rudolph L, et al. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology. 2008;134:1752-1763.
23. Ikeda K, Saitoh S, Tsubota A, et al. Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer. 1993;71:19-25.
24. Chen WT, Chau GY, Lui WY, et al. Recurrent hepatocellular carcinoma after hepatic resection: prognostic factors and long-term outcome. Eur J Surg Oncol. 2004;30:414-420.
25. Duff JP, Vardanian A, Benjamin E, et al. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg. 2007;246:502-559; discussion 509-511.
26. Shinagawa T, Ohto M, Kimura K, et al. Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of real-time ultrasonography. A study in 51 patients. Gastroenterology. 1984;86:495-502.
27. Sheu JC, Sung JL, Chen DS, et al. Early detection of hepatocellular carcinoma by real-time ultrasonography. A prospective study. Cancer. 1985;56:660-666.
28. Wong LL, Limm WM, Severino R, et al. Improved survival with screening for hepatocellular carcinoma. Liver Transpl. 2000;6:320-325.
29. Tong MJ, Blatt LM, Kao VW. Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America. J Gastroenterol Hepatol. 2001;16:553-559.
30. Durazo FA, Blatt LM, Corey WG, et al. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol. 2008;23:1541-1548.